You are here: Industry Insights > Sanofi

News List

Sanofi executive lays out case for taxpayer funding—and exclusive licensing—on Zika vaccine R&D fiercepharma
May 27, 2017
Sanofi has been publicly chastised by lawmakers and public health groups for its proposed Zika vaccine deal with the U.S. Army. Now, an executive is explaining the rationale behind the company’s development plan and defending against claims his company is
FDA approves Sanofi and Regeneron’s Kevzara for adult rheumatoid arthritis pharmaceutical-technology
May 27, 2017
Sanofi and Regeneron Pharmaceuticals’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely active rheumatoid arthritis (RA).
Sanofi and Exscientia Pen €250M Drug Discovery Deal contractpharma
May 10, 2017
Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, has entered a strategic research collaboration and license option agreement with Sanofi in the area of metabolic disease.
FDA accepts Sanofi and Regeneron’s biologics license resubmission europeanpharmaceuticalreview
May 03, 2017
The US Food and Drug Administration (FDA) has accepted the resubmission of Sanofi and Regeneron Pharmaceuticals’ biologics license application for Kevzara (sarilumab) as a Class I response with a two month review timeline.
Despite foundering Dengvaxia launch, Sanofi puts up 13.2% vaccines growth in Q1 fiercepharma
May 03, 2017
Sanofi’s vaccines business leaned on strong performances from pediatric, flu and travel shots on the way to 13.2% growth in the first quarter—because it certainly couldn't depend on the foundering dengue vaccine Dengvaxia.
U.S. supplies of Sanofi Pasteur’s yellow fever vaccine set to run out, CDC reports fiercepharma
May 03, 2017
The ongoing global yellow fever vaccine shortage has hit the U.S., as Sanofi Pasteur’s YF-VAX, the only FDA-approved prophylactic shot for the disease, will soon run out, according to the CDC.
Sanofi launches lawsuit against Mylan over "illegal business practices" pharmafile
April 27, 2017
In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has...
U.S. Army can't add a pricing safeguard to Sanofi's Zika vaccine license, official says americanpharmaceuticalreview
April 26, 2017
A U.S. Army official responded to concerns from nonprofit KEI about the government's proposed Zika vaccine license transfer to Sanofi.
Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia financialexpress
April 17, 2017
Kalra is an MBA from IIM Lucknow and brings with him over two decades of varied experience in global and country roles
Evotec Achieves Sanofi Diabetes Milestone contractpharma
April 07, 2017
Achieves preclinical proof-of-concept, triggering €3.0 million payment

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page